USC.edu
Are You a Patient?

Yan Ning

Clinical Research Data Specialist Lead

Image of Yan Ning
Is this your profile? Click to edit
Phone +1 323 409 4365
Email [email protected]
CTSI Profile

Publications

  • “I have some place to be myself”: components of belonging in LGBTQ+ communities. Cult Health Sex. 2026 Aug 14; 1.. View in PubMed
  • A 5-HT6R agonist alleviates cognitive dysfunction after traumatic brain injury in rats by increasing BDNF expression. Behav Brain Res. 2022 09 05; 433:113997.. View in PubMed
  • Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer Patients. Cancers (Basel). 2020 Oct 13; 12(10).. View in PubMed
  • A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer. PLoS One. 2020; 15(9):e0239439.. View in PubMed
  • Single Nucleotide Polymorphisms in MiRNA Binding Sites of Nucleotide Excision Repair-Related Genes Predict Clinical Benefit of Oxaliplatin in FOLFOXIRI Plus Bevacizumab: Analysis of the TRIBE Trial. Cancers (Basel). 2020 Jun 30; 12(7).. View in PubMed
  • A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials. Eur J Cancer. 2020 05; 131:89-97.. View in PubMed
  • Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenib. Cancer Sci. 2020 Feb; 111(2):441-450.. View in PubMed
  • Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial. Eur J Cancer. 2019 01; 107:100-114.. View in PubMed
  • Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients. Int J Cancer. 2019 05 15; 144(10):2567-2577.. View in PubMed
  • Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer. Pharmacogenomics J. 2018 09; 18(5):623-632.. View in PubMed

Similar People